Tennessee Oncology, PLLC
Nashville, Tennessee, United States
Medical clinic in Nashville, Tennessee
3443 Dickerson Pike #760, Nashville, TN 37207
About Tennessee Oncology, PLLC
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
SCRI Development Innovations, LLC
105
Pfizer
42
Eli Lilly and Company
35
Hoffmann-La Roche
27
Bristol-Myers Squibb
23
Gilead Sciences
13
Genentech, Inc.
11
Boehringer Ingelheim
7
Novartis Pharmaceuticals
5
Amgen
4
BeiGene
4
Clinical Trials at Tennessee Oncology, PLLC
During the past decade, Tennessee Oncology, PLLC conducted 181 clinical trials. In the 10-year time frame, 181 clinical trials started and 142 clinical trials were completed, i.e. on
average, 78.5% percent of trials that started reached the finish line to date. In the past 5 years, 67 clinical trials started and 53 clinical trials were completed. i.e. 79.1%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
TLK286 (Telcyta) vs. Doxil/Caelyx or Hycamtin in Platinum Refractory or Resistant Ovarian Cancer
2003-06-01
2006-12-01
Completed
440
Study of TLK286 (Telcyta) vs. Gefitinib in Locally Advanced or Metastatic Non-Small Cell Lung Cancer
2005-05-01
Completed
520
Carboplatin, Paclitaxel and TLK286 (Telcyta) as First-Line Therapy in Advanced Non-Small Cell Lung Cancer
2004-08-01
2009-05-01
Completed
100
Oral Topotecan Versus Docetaxel in Second-Line Treatment of Non-Small Cell Lung Cancer
2000-11-01
2009-01-01
Completed
80
Adjuvant Docetaxel and Estramustine Phosphate for High Risk Localized Prostate Cancer
2004-08-01
2007-05-01
Completed
30
Chemotherapy Plus Gefitinib Followed by Chemotherapy, Radiation Therapy, and Gefitinib For Head and Neck Cancer
2003-10-01
2009-01-01
Completed
50
Weekly Docetaxel Versus Weekly Docetaxel/Gemcitabine in the Treatment of Non-Small Cell Lung Cancer in Elderly Patients
2001-08-01
2009-01-01
Completed
346
Preoperative Therapy in Patients With Stages IB, II, IIIA, and Selected IIIB Patients With Non-Small Cell Lung Cancer
2004-04-01
2008-12-01
Completed
75
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Tennessee Oncology, PLLC" #1 sponsor was "SCRI Development Innovations, LLC" with 105 trials, followed by "Pfizer" with 42 trials
sponsored, "Eli Lilly and Company" with 35 trials sponsored, "Hoffmann-La Roche" with 27 trials sponsored and "Bristol-Myers Squibb"
with 27 trials sponsored. Other sponsors include 126 different institutions and
companies that sponsored additional 73 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Tennessee Oncology, PLLC"
#1 collaborator was "Genentech, Inc." with 27 trials as a collaborator, "Novartis" with 22 trials as a collaborator, "Bristol-Myers Squibb" with 11 trials as a collaborator, "GlaxoSmithKline" with 11 trials as a collaborator and "Bayer" with 9 trials as a collaborator. Other collaborators include 116 different institutions and companies that were
collaborators in the rest 60 trials.
Clinical Trials Conditions at Tennessee Oncology, PLLC
According to Clinical.Site data, the most researched conditions in "Tennessee Oncology, PLLC" are
"Breast Cancer" (33 trials), "Multiple Myeloma" (17 trials), "Non-Small Cell Lung Cancer" (16 trials), "Metastatic Breast Cancer" (15 trials) and "Ovarian Cancer" (14 trials). Many other conditions were trialed in "Tennessee Oncology, PLLC" in a lesser frequency.
Clinical Trials Intervention Types at Tennessee Oncology, PLLC
Most popular intervention types in "Tennessee Oncology, PLLC" are "Drug" (344 trials), "Biological" (38 trials), "Other" (11 trials), "Procedure" (6 trials) and "Radiation" (4 trials). Other intervention types were less common.
The name of intervention was led by "Carboplatin" (35 trials), "Placebo" (34 trials), "Paclitaxel" (27 trials), "Gemcitabine" (26 trials) and "Bevacizumab" (23 trials). Other intervention names were less common.
Clinical Trials Genders at Tennessee Oncology, PLLC
The vast majority of trials in "Tennessee Oncology, PLLC" are
315 trials for "All" genders, 34 trials for "Female" genders and 14 trials for "Male" genders.
Clinical Trials Status at Tennessee Oncology, PLLC
Currently, there are NaN active trials in "Tennessee Oncology, PLLC".
undefined are not yet recruiting,
57 are recruiting,
56 are Active, not recruiting,
and 1 are Enrolling by invitation.
In total, there were 191 completed trials in Tennessee Oncology, PLLC,
2 suspended trials,
and 48 terminated clinical trials to date.
Out of the total trials that were conducted in Tennessee Oncology, PLLC, 113 "Phase 1"
clinical trials were conducted, 193 "Phase 2" clinical
trials and 85 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 4 trials, and there were
also 3 trials that are defined as “Not Applicable".